HIVAging
Meeting category
Date(s)
2 Oct 2017 - 3 Oct 2017
Location
New York, United States
Organizer
Titanium Level Support
Sponsor logos
ViiW

International Workshop on HIV & Aging 2017

Related Enduring Materials

Enduring Materials

Day 1 - Monday, 2 Octeber 2017

Session 1: Biological aging -
Chairs
 Julian Falutz
Julian Falutz, MD
McGill University, Canada
Joseph Margolick
Joseph Margolick, MD, PhD
Johns Hopkins Bloomberg School of Public Health, Baltimore
Phenotype of aging (not available)
George Kuchel
George Kuchel, MD
UCONN Health, USA
Clinical Trials Targeting Aging to Extend Healthy Lifespan
Jamie Justice
Jamie Justice, PhD
Wake Forest School of Medicine, USA
The biology of superagers
Nir Barzilai
Nir Barzilai, MD
Albert Einstein College of Medicine, USA
Session 2: Biological aging : abstract-driven presentations -
Chairs
Charles Flexner, MD
Johns Hopkins University School of Medicine, United States
Inability of ART to Restore Age-Appropriate Epigenetic Patterns in HIV-Infected Adults
Dr Beth Jamieson-Karavodin, David Geffen
School of Medicine at UCLA, USA
Mitochondrial DNA variation associated with gait speed decline among older HIV-infected non-Hispanic white males
Jing Sun
Johns Hopkins Bloomberg School Of Public Health, USA
Limited evidence of biological aging in early-treated HIV-infected children
Stephanie Shiau
Columbia University, USA
Metformin suppresses human cytomegalovirus infection: an underlying mechanism for metformin’s “geroprotective” effect?
Sean Leng
Johns Hopkins University School of Medicine, USA
Session 3: Aging and CNS safety of HIV interventions -
Chairs
Moore, David
David Moore, PhD
University of California, San Diego, United States
placeholder3
Bruce Brew, MD
St. Vincent's Hospital, Australia
HIV eradication strategies and the CNS
Serena Spudich
Serena Spudich, MD
Yale University, USA
Session 4: Aging and CNS safety of HIV interventions: abstract-driven presentations -
Chairs
Madhav Thambisetty
Madhav Thambisetty, MD
NIH, United States
Scott Letendre
Scott Letendre, MD
University of California San Diego, United States
OMICS in the context of aging and Alzheimer's disease
Madhav Thambisetty, MD
National Institutes of Health (NIH/NIA), United States
Abstract driven presentations
Common SNPs in the HFE (Hemochromatosis) Gene are Associated with Neurocognitive Impairment and Aging-Related Neurodegenerative Processes in HIV+ Adults (not available)
Asha Kallianpur
Cleveland Clinic Foundation, USA
Lower brain volume and elevated chronic monocyte activation correlate with cognitive impairment in well-controlled older HIV+ individuals (not available)
Tricia Burdo
Temple University Lewis Katz School Of Medicine, USA
Cognition, Mood and Quality of Life in 706 HIV+ Men in Canada
Marie-Josée Brouillette
McGill University Health Centre, Canada
Cognitive Impairment in Symptomatic HIV Over age 60
Shireen Javandel
UC San Francisco, Memory & Aging Center, USA

Day 2 - Tuesday, 3 October 2017

Session 5: The effect of exercise and diet on aging -
Chair
Russell Tracy, PhD
University of Vermont (UVM), United States
Exercise and aging
Wendy Kohrt
Wendy Kohrt, PhD
University of Colorado, USA
Stress and aging (not available)
Gretchen Neigh
Gretchen Neigh , PhD
Virginia Commonwealth University, USA
Interrelationships of nutrition and aging (not available)
Connie Bales
Connie Bales, PhD
Duke University, USA
Session 6: The effect of exercise and diet on aging: abstract-driven presentations -
Chairs
Meredith Greene, MD
Indiana University School of Medicine, United States
Todd Brown, MD, PhD
Johns Hopkins University, United States
Adherence to recommendations from comprehensive geriatric assessment in an HIV+ population (not available)
placeholder3
Christiana Bitas
Weill Cornell Medical College, USA
Lean mass declines consistently over 10 Years in HIV-Infected adults on antiretroviral therapy, with patterns differing by sex (NOTE: results not yet published)
Jordan Lake
Jordan Lake, MD, MSc
UTHealth, USA
Steps count is associated with adverse health outcomes in HIV patients better than traditional HIV variables
Giovanni Guaraldi, MD
University of Modena and Reggio Emilia, Italy
"The relationships between CD4+ and CD8+ T-cell responses to human cytomegalovirus, circulating inflammatory markers, and frailty in HIV- and HIV+ men in the Multicenter AIDS Cohort Study " (not available)
Joseph Margolick, MD, PhD
Johns Hopkins Bloomberg School of Public Health, United States
Session 7: Delivering research progress to patients -
Chairs
Jules Levin, MS
National AIDS Treatment Advocacy Project, United States
Julian Falutz, MD, FRCPC
McGill University, Canada
Kristine Erlandson, MD, MS
University of Colorado Denver- Anschutz Medical Campus, United States
Current reality: The San Francisco experience
Meredith Greene, MD
Indiana University School of Medicine, United States
Current reality: The New York experience
Eugenia Siegler, MD
Weill Cornell Medicine, New York City, United States
The community perspective
Jules Levin, MS
National AIDS Treatment Advocacy Project, United States
The researcher perspective
Phyllis Tien
Phyllis Tien, MD
University of California, USA
The NIH perspective
Maureen Goodenow
Maureen Goodenow, PhD
NIH / OAR,USA
Session 8 - 15:00
15:00 EST
Update from NIH
Maureen Goodenow
Maureen Goodenow, PhD
Office of AIDS Research (OAR), USA
Overview
Welcome

We would like to thank all the 120 participants of the 8th edition of the International Workshop on HIV & Aging (2 - 3 October 2017, New York, NY) for their invaluable contribution in making this meeting such a success.

On behalf of the Organizing Committee, we would also like to express our gratitude to ViiV Healthcare, Gilead, Janssen and  Mylan for their generous support. 

Committees
Organizing Committee

The members of the Organizing Committee (OC) discuss, on a frequent basis, the scientific programme of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts.

Organizing Committee
Support
Titanium Level
Gold Level
Bronze Level
Support
Endorsers
Media partner
Language